Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Anti-Cancer Drugs|July 29, 2011
Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS statusDominik P Modest, Sebastian Stintzing, Ruediger P Laubender, et al.
European Journal of Cancer (Oxford, England : 1990)|April 16, 2024
Unresectable biliary tract cancer: Current and future systemic therapyDanmei Zhang, Klara Dorman, C Benedikt Westphalen, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 1, 2024
Identification of a gene expression signature associated with brain metastasis in colorectal cancerMarlies Michl, Francesco Taverna, Christine Woischke, et al.
Frontiers in Neurology|March 22, 2024
Risk factors for intracerebral hemorrhage in small-vessel disease and non-small-vessel disease etiologies-an observational proof-of-concept studyPhilipp Arndt, Christian Chahem, Michael Luchtmann, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 26, 2021
Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal CancerSophie L Boos, Leon P Loevenich, Sebastian Vosberg, et al.
Lung Cancer (Amsterdam, Netherlands)|August 9, 2021
Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT)Amanda Tufman, Jens Neumann, Farkhad Manapov, et al.
Clinical Colorectal Cancer|July 1, 2015
Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic FactorsMarlies Michl, Johannes Thurmaier, Gabriele Schubert-Fritschle, et al.
Allergy|February 23, 2019
Lung disease in STAT3 hyper-IgE syndrome requires intense therapyCarolin Kröner, Jens Neumann, Julia Ley-Zaporozhan, et al.
Acta Neuropathologica|November 14, 2014
Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental strokeJens Neumann, Monika Riek-Burchardt, Josephine Herz, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2022
First-line fluoropyrimidine plus bevacizumab followed by irinotecan-escalation versus initial fluoropyrimidine, irinotecan and bevacizumab in patients with metastatic colorectal cancer - Final survival and per-protocol analysis of the randomised XELAVIRI trial (AIO KRK 0110)Arndt Stahler, Dominik P Modest, Ludwig Fischer von Weikersthal, et al.
Pageof 15